Management

Sharklet Technologies, Inc. is managed by seasoned executives who bring a diverse set of complementary skills in technology, life sciences and consumer goods. Learn more about our executive team, advisors and board.

  • Joe Bagan, Chairman of the Board
    • Joe Bagan is chairman of the Sharklet Technologies’ board of directors. He leads the company’s business development activities in commercial and healthcare markets. Mr. Bagan brings more than 20 years of strategic leadership and executive management experience to the position.

      In addition to leading Sharklet Technologies, Mr. Bagan is co-founder of RevGen Partners, a consultancy focused on revenue audit/assurance and revenue recovery for the healthcare and telecommunications industries. He also serves on the board of directors of an anti-infective drug company that works in partnership with a Chinese pharmaceutical company. The company is working to develop and commercialize the first anti-infective peptide suitable for in-vivo and systemic use in humans.

      Before his work in healthcare, Mr. Bagan held a number of executive positions in the communications industry. He was senior vice president of Adelphia Communications’ southeast region where he led all business functions and held full P&L responsibility for a seven-state territory. Prior to that, he was CFO at Ricochet Wireless Networks. During his tenure, he guided the company’s fundraising efforts and successfully completed a B round of financing. Mr. Bagan also has expertise in leading multi-billion initiatives as he served in various executive capacities at AT&T Broadband from 2000 to 2002 which included roles such as merger leader, chief information officer and senior vice president of billing operations. Mr. Bagan was recruited to AT&T from Arthur Andersen where he was the partner in charge of the Southwestern United States’ consulting practice in several key industries.

  • Dr. Anthony Brennan, Founder

    • Chairman of the Scientific Advisory Board, Principal Investigator for Sharklet™ Patents

      Dr. Anthony Brennan is the founder of Sharklet Technologies and chairman of the company’s Scientific Advisory Board. Dr. Brennan discovered and developed Sharklet™, the company’s core surface technology. He is a world-renowned research scientist and is an endowed professor in the Materials Science and Biomedical Engineering department at the University of Florida. Dr. Brennan continues to teach and perform research at UF. He is widely recognized in surface sciences and acclaimed for his work in microorganism control.

      Dr. Brennan’s research program centers on the development and evaluation of biomedical materials with special emphasis on biomedical composites and their interfacial behavior with respect to implantation. His research group has earned 12 Ph.D.’s and 26 MS degrees, authored or co-authored more than 100 publications, and secured 27 invention disclosures and seven patents.

      As associate director of the Center for Macromolecular Science and Engineering, Professor Brennan has initiated and participated in numerous interdisciplinary research programs with the Colleges of Engineering, Liberal Arts and Sciences and Dentistry. Within the business community, Dr. Brennan serves as reviewer of numerous publications and serves as consultant to the medical device industry. He previously held an executive position at Coors Biomedical Company which provided research and manufacturing in bio-ceramics for Johnson & Johnson. Dr. Brennan received his Ph.D. in materials engineering science from Virginia Polytechnic Institute and State University.

  • Mark Spiecker, Chief Executive Officer
    • Mark Spiecker serves as chief executive officer for Sharklet Technologies. He directs strategy and a wide range of business functions including operations, business development, marketing and communications. Mr. Spiecker brings more than 15 years of high-level management experience to the company. He boasts a successful track record in corporate development, operations management, mergers and acquisitions, and strategic communications earned from positions at a number of high-profile companies.

      Prior to joining Sharklet Technologies, Mr. Spiecker was director of restructuring and investor relations for Adelphia Communications Corporation which at the time was the nation’s fifth largest U.S. cable operator. Before joining Adelphia, he was responsible for client services and operations structure development at 360networks in the western United States and Canada. He developed experience in the product manufacturing industry as he managed human resources and process engineering for Louisiana-Pacific Corporation, a home building products manufacturer.

  • Kenneth Chung, Director of Product Development
    • Kenneth Chung is director of R&D and maintains the distinction as one of the original researchers on the Sharklet™ surface pattern. In addition to his research role, Mr. Chung leads Sharklet Technologies’ efforts to manufacture Sharklet in preparation for commercial availability.

      As a graduate student at the University of Florida in the Materials Science and Engineering department, Mr. Chung’s research focused on the design, fabrication and testing of engineered surface technologies in collaboration with physicians, engineers, biologists and chemists. Of particular note, Mr. Chung led the studies investigating the Sharklet surface for biofilm inhibition of S. aureus. He received his M.S. in materials science and engineering from the University of Florida and his B.S. in materials science and engineering from the University of California, Berkeley.

  • Shravanthi Reddy, Director of Research
    • Dr. Reddy serves as Sharklet Technologies’ principal investigator for all the company’s product development work funded through the National Institutes of Health(NIH) Small Business Innovation Research (SBIR) program. She leads the development of the Sharklet Urinary Catheter prototype and conducts bacterial testing of the prototype against a uropathogenic E. coli. In addition, she supports other research projects performed both in Sharklet Technologies’ laboratories as well as those conducted by corporate partners.

      Dr. Reddy holds a PhD in chemical engineering from the University of Texas at Austin, where her research focused on microfluidics in the Step and Flash Imprint Lithography process. She earned a BSE degree in Chemical Engineering from Princeton University. She received a Humboldt Fellowship for postdoctoral research at the Max Planck Institute in Stuttgart, Germany, researching the replication of biomimetic gecko setae for switchable adhesion on polymer surfaces. Her work has been published in numerous scientific journals including Advanced Materials, Microelectronic Engineering, Physics of Fluids, International Nanoimprint and Nanotechnology Abstracts, among others.

    • Scientific Advisory Board

  • Dr. Anthony Brennan
    • Dr. Brennan is inventor of Sharklet™, the scientific founder of Sharklet Technologies and chairman of the company’s Scientific Advisory Board. He has contributed to more than 100 publications and holds several patents in the bioengineering and polymer chemistry fields. He also holds nearly a decade of experience in the biomedical device industry where he was instrumental in numerous concept-to-product successes and clinical trials. In addition to his role at Sharklet Technologies, Dr. Brennan is an endowed professor in the Materials Science and Biomedical Engineering department at the University of Florida. He is widely recognized in the surface sciences community and acclaimed for his work in microorganism control.
  • Dr. Jamie Landman
    • Dr. Landman is director of Minimally Invasive Urology at Columbia University Medical Center and an associate professor in the Department of Urology in Columbia University’s School of Medicine. He has authored more than 100 peer-reviewed publications as well as many case reports, reviews, editorials, book chapters and patents on biomedical devices and methods related to urology. He serves as a reviewer for several urology-related journals. As a Sharklet Technologies Scientific Advisory Board member, Dr. Landman provides expertise in developing bacterial testing protocols and analysis of results.
  • Dr. Puneet Khanna
    • Dr. Khanna draws from vast experience as top cardiologist, consultative experience and professional leadership in advising Sharklet Technologies. Today, Dr. Khanna practices cardiology at Eisenhower Medical Center in Rancho Mirage, Calif. through a leading cardiology group that he helped found. He has personally performed more than 8,0000 interventional cardiology procedures and is consistently listed among the “Top Doctors” in America.

      In addition to his active practice, Dr. Khanna has been personally involved with the evolution and development of new medical devices for the past decade. In keeping with this leadership, he has authored manuscripts, scientific abstracts and articles in peer-reviewed journals. He has been an investigator for leading medical devices and clinical trials.

  • Dr. Daniel Perlman
    • Dr. Perlman brings a wealth of experience and insight to the Advisory Board. He is president of the Infectious Disease Society of America (IDSA) Colorado Chapter and serves on a number of boards and committees. He serves in a leadership capacity at several hospitals including the Medical Executive Committee at Porter Adventist Hospital in Denver. In addition, Dr. Perlman is founder and president of Greater Denver Infectious Diseases, an organization that delivers best practices in infectious disease diagnosis and management in the Denver market. This vast experience is especially valuable in Dr. Perlman’s healthcare consulting activities as he is sought for his perspective and guidance on innovative products and technologies.
  • Dr. Michael Pietrzak
    • Dr. Pietrzak is a board-certified emergency medicine specialist and a retired United States Air Force Colonel. He is the founder and president of Knowledge Management Solutions, a consulting entity that focuses on areas where medicine and security intersect. Through this organization, he oversees a number of high-value projects for the private and public sector, one of which includes Project ER One. This is a federally funded and mandated project to develop design features for emergency departments so they are capable of managing the medical consequences of terrorism.

      Dr. Pietrzak is also the executive director of the International Brain Injury Association. During his military career, he held a number of high-level positions. As Commander of the 11th Medical Group, he held final executive and financial authority over USAF medical facilities in the nation’s capital. He was also chief medical officer of TRICARE Southwest where he managed $1 billion in clinical programs.

  • Dr. Kenneth Tucker
    • Dr. Kenneth D. Tucker, MS, PhD has more than 20 years’ experience conducting and directing scientific research and development to characterize and treat infectious diseases. Currently, he is a senior medical scientist for the Tauri Group supporting a contract to the Department of Defense for advanced development of therapeutics in the Transformational Medical Technologies Program. In this position he advises the government on extramural projects and programs ranging from discovery science through preclinical development. Prior to working in the biodefense, Kenneth carried out both discovery and development research, from inception through production, on a variety of bacteria that cause disease in humans.

    • Board of Directors

    Joe Bagan, Chairman of the Board
    Dr. Anthony Brennan, Founder of Sharklet Technologies
    Dan Seff, Partner at The Seff Group, CPA
    Greg Garvis, Owner at HRVP
    Al Perkins, Entrepreneur
    Greg Carlisle, Limestone Ventures